JR Vyas, CMD, Dishman Pharma in an interview to CNBC-TV18 clarified that the company had not received any warning from US FDA on Clovis issue.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
JR Vyas, CMD, Dishman Pharma in an interview to CNBC-TV18 clarified that the company had not received any warning from US FDA on Clovis issue.
| Subscribe To Our Free Newsletter |
